New NICE migraine recommendation to benefit thousands

Thousands of NHS patients are set to benefit from a new treatment for acute migraine as the National Institute for Health and Care Excellence (NICE) recommends rimegepant for adults.

In final draft guidance, NICE has recommended rimegepant – otherwise known as Pfizer’s Vydura – for adults who have tried at least two triptans, but did not work.

The treatment is also recommended for adults who either cannot take triptans or they were not tolerated – this is the same for those who have unsuccessfully tried nonsteroidal anti-inflammatory drugs and paracetamol.

It is expected to benefit around 13,000 people once it is available on the NHS.

The medicine works by blocking the release of a protein called calcitonin gene-related peptide around the brain.

Clinical trial evidence showed rimegepant had a higher likelihood of reducing pain at two hours than a placebo.

Director of medicines evaluation at NICE, Helen Knight, said: “This is the first and only NICE-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment.”

She continued: “Migraine is a condition described in comments to NICE from carers and people with migraine as an invisible disability that affects all aspects of life including work, education, finances, mental health, social activities, and family.”

Final guidance is expected to be published in October for rimegepant.

Image credit: iStock

NHE September/October 2023

NHE September/October 2023

Empowering the next generation to lead the way in hard-to-treat cancers.

The September/October 2023 edition of NHE brings you expert comment and analysis on a range of key health sector topics, from digital transformation to navigating post-pandemic challenges.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

National Health Executive Podcast

Ep. 36
How interoperability can support the NHS's core goals
with Ed Platt

In episode 36 of the National Health Executive podcast, we were joined by Omnicell’s UK professional services director, Ed Platt, to discuss interoperability in the NHS, practical examples of where it can be leveraged best, the importance of the health service's digital transformation journey and more.

More articles...

View all